Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Senate 'Cures' Companion Advances; Funding Unclear

This article was originally published in Scrip

Executive Summary

A set of 19 bills aimed at improving the efficiency and pace at which the FDA and the National Institutes of Health (NIH) do their work is now on its way the full Senate for consideration after the chamber's Health, Education, Labor and Pensions (HELP) Committee agreed during an April 6 markup session on the remaining pieces of legislation.

Advertisement

Related Content

Antibiotic Incentives Helped Spero Get Where It Is Today

Topics

Advertisement
UsernamePublicRestriction

Register

SC064915

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel